21.06.2022 | ‘Biofluid biomarkers in atypical parkinsonism’ by Per Svenningsson, Karolinska Institute, Department of Clinical Neuroscience, Stockholm, Sweden. SIGN UP here
24.06.2022, 10-11h CEST | ‘Caring HD: the experience of the French National Reference Centre’ by Anne- Catherine Bachoud Levi, Hôpital Henri Monodor APHP, France. SIGN UP here
28.06.2022 | ‘Magnetic resonance imaging in the diagnostic assessment of cerebellar ataxias’ by Jennifer Faber, German Center for Neurodegenerative Disorders, Bonn, Germany. SIGN UP here
05.07.2022 | ‘Young onset Parkinson’s disease – What is the difference?’ by Bart Post, Radboud University Medical Center, Nijmegen, the Netherlands. SIGN UP here
12.07.2022 | ‘Importance of autopsies in leukodystrophies’ by Marianna Bugiani, Amsterdam University Medical Center, the Netherlands. SIGN UP here
13.09.2022 | ‘Vanishing white matter’ by Marjo van der Knaap, Amsterdam University Medical Center, the Netherlands. SIGN UP here
20.09.2022 |‘Tau-targeting Therapies: Where are we heading to?’ by Günter Höglinger, Hannover Medical School, Germany. SIGN UP here
27.09.2022 | ‘Clinical and genetic predictors of subthalamic nucleus deep brain stimulation in Parkinson’s disease’ by Daniel Weiß, Hertie Institute for Clinical Brain Research, University of Tübingen, Germany. SIGN UP here
04.10.2022 | ‘CACNA1A-related disorders: clinical presentation and therapeutic options’, by Elisabetta Indelicato, Medical University Innsbruck, Austria, SIGN UP here
11.10.2022 | ‘Krabbe disease – natural history and treatment options’ by Ingeborg Krägeloh-Mann and Samuel Gröschel, University Hospital Tübingen, Germany. SIGN UP here
18.10.2022 | ‘DBS in Dystonia – Targets, programming and therapeutic challenges’ by Philipp Capetian, University Hospital Würzburg, Germany. SIGN UP here
25.10.2022 | ‘VPS13A and XK bulk lipid transfer diseases (formerly the now obsolete Levine-Critchley syndrome)’ by Adrian Danek, University Hospital Munich, Germany. SIGN UP here
08.11.2022 | ‘When is it appropriate to suspect a metabolic disorder in a child with chorea?’ by Juan Dario Ortigoza, Sant Joan de Déu, Barcelona, Spain. SIGN UP here
08.11.2022 | ‘Telerehabilitation in RND: an update’ by Luigi Lavorgna, University Luigi Vanvitelli, Neaples, Italy. SIGN UP here
22.11.2022 | ‘Use of Biomarkers to monitor the presymptomatic phase of Genetic FTD: research advances for clinical trial readiness’ by Dario Saracino and Harro Seelaar, Brain and Spine Institute, Paris, France; Erasmus MC- Rotterdam, the Netherlands. SIGN UP here
29.11.2022 | ‘DBS in acquired Dystonia’ by Anne Koy, University Hospital Cologne, Germany. SIGN UP here
06.12.2022 | ‘Update in synuclein PET tracer development’ by Johannes Levin, University Hospital Munich, Germany. SIGN UP here
—
27-28. October 2022, Hybrid Course “Current challenges of semiology in pediatric neurology” Vall d’Hebron, Barcelona, Spain. Programme-see attachment. Registration at: https://aula.vallhebron.com/